Tag: Nasdaq:KDNY
Chinook Therapeutics Announces Promotions of Tom Frohlich to Chief Operating Officer...
SEATTLE, June 09, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development...
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule...
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and...